Association of asymmetric dimethylarginine with sickle cell disease-related pulmonary hypertension

Haematologica

Volumn 93, Issue 9, 2008, Pages 1410-1412

  Landburg, Precious P ^a   Teerlink, Tom ^b   Van Beers, Eduard J ^c   Muskiet, Frits A J ^d   Kappers Klunne, Mies C ^e   Van Esser, Joost W J ^e   Mac Gillavry, Melvin R ^f   Biemond, Bart J ^c   Brandjes, Dees P M ^f   Duits, Ashley J ^a   Schnog, John John ^a,e,f  

^a Red Cross Blood Bank Foundation Curaçao   (Netherlands Antilles)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f SLOTERVAART HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

N(G),N(G) DIMETHYLARGININE;

ADULT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; ENZYME ACTIVITY; FEMALE; HEMOLYSIS; HUMAN; LETTER; MALE; PROTEIN METABOLISM; PULMONARY HYPERTENSION; SICKLE CELL ANEMIA; THALASSEMIA;

ADULT; ANEMIA, SICKLE CELL; ARGININE; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED;

EID: 50849112743     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: 10.3324/haematol.12928     Document Type: Letter

References (11)

1. Gladwin MT, Sachdev V, Jison ML, Shizukuda Y, Plehn JF, Minter K, et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl Med 2004;350:886-95.
2. Landburg PP, Teerlink T, Muskiet FA, Duits AJ, Schnog JB. Plasma concentrations of asymmetric dimethylarginine, an endogenous nitric oxide synthase inhibitor, are elevated in sickle cell patients but do not increase further during painful crisis. Am J Hematol 2008;83:577-9.
3. Wilcken DE, Sim AS, Wang J, Wang XL. Asymmetric dimethylarginine (ADMA) in vascular, renal and hepatic disease and the regulatory role of L-arginine on its metabolism. Mol Gen Metabol 2007;91:309-17.
4. Kielstein JT, Bode-Boger SM, Hesse G, Martens-Lobenhoffer J, Takacs A, Fliser D, et al. Asymmetrical dimethylarginine in idiopathic pulmonary arterial hypertension. Aterioscler Thromb Vasc Biol 2005;25:1414-8.
5. Skoro-Sajer N, Mittermayer F, Panzenboeck A, Bonderman D, Sadushi R, Hitsch R, et al. Asymmetric dimethylarginine is increased in chronic thromboembolic pulmonary hypertension. Am J Resp Crit Care Med 2007;176:1154-60.
6. van Beers EJ, van Eck-Smit BL, Mac Gillavry MR, van Tuijn CF, van Esser JW, Brandjes DP, et al. Large and mediumdized pulmonary artery obstruction does not play a role of primary Importance in the etiology of sickle-cell disease-associated pulmonary hypertension. Chest 2008;133:646-52.
7. Schnog JB, Rojer RA, Mac Gillavry MR, Ten Cate H, Brandjes DP, Duits AJ. Steady-state sVCAM-1 serum levels in adults with sickle cell disease. Ann Hematol 2003;82:109-13.
8. Osanai T, Saitoh M, Sasaki S, Tomita H, Matsunaga T, Okumura K. Effect of shear stress on asymmetric dimethylarginine release from vascular endothelial cells. Hypertension 2003;42:985-90.
9. Arrigoni FI, Vallance P, Haworth SG, Leiper JM. Metabolism of asymmetric dimethylarginines is regulated in the lung developmentally and with pulmonary hypertension induced by hypobaric hypoxia. Circulation 2003;107:1195-201.
10. Morris CR, Kato GJ, Poljakovic M, Wang X, Blackwelder WC, Sachdev V, et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 2005;294:81-90.
11. Sachdev V, Machado RF, Shizukuda Y, Rao YN, Sidenko S, Ernst I, et al. Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J Am Coll Cardiol 2007;49:472-9.